NasdaqCM - Delayed Quote USD

Lisata Therapeutics, Inc. (LSTA)

2.7750

-0.0350

(-1.25%)

At close: 4:00 PM EDT

Key Events

Loading Chart for LSTA

9/21 12:03 PM

DELL

Previous Close 2.8100
Open 2.8100
Bid --
Ask --
Day's Range 2.6500 - 2.9454
52 Week Range 1.9500 - 4.5300
Volume 5,473
Avg. Volume 13,170
Market Cap (intraday) 23.053M
Beta (5Y Monthly) 1.08
PE Ratio (TTM) --
EPS (TTM) -2.5800
Earnings Date Aug 12, 2024 - Aug 16, 2024
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est 14.50

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.

25

Full Time Employees

December 31

Fiscal Year Ends

Sector

Industry

Trailing total returns as of 5/13/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

LSTA

1.65%

S&P 500

9.47%

1-Year Return

LSTA

15.91%

S&P 500

26.61%

3-Year Return

LSTA

87.06%

S&P 500

28.51%

5-Year Return

LSTA

93.49%

S&P 500

81.21%

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Lisata Therapeutics, Inc.

2.7750

-1.25%

Mkt Cap 23.053M

Industry Biotechnology

Aligos Therapeutics, Inc.

0.6846

-6.26%

Mkt Cap 53.474M

Industry Biotechnology

Kronos Bio, Inc.

1.0200

0.00%

Mkt Cap 61.296M

Industry Biotechnology

Assembly Biosciences, Inc.

13.39

-0.07%

Mkt Cap 73.414M

Industry Biotechnology

1.4800

+7.25%

Mkt Cap 13.912M

Industry Biotechnology

Reneo Pharmaceuticals, Inc.

1.5900

-12.15%

Mkt Cap 53.139M

Industry Biotechnology

Sensei Biotherapeutics, Inc.

1.5700

+3.97%

Mkt Cap 39.377M

Industry Biotechnology

Instil Bio, Inc.

11.80

+1.90%

Mkt Cap 76.746M

Industry Biotechnology

Lixte Biotechnology Holdings, Inc.

2.6715

+4.76%

Mkt Cap 6.009M

Industry Biotechnology

Salarius Pharmaceuticals, Inc.

0.4900

+0.51%

Mkt Cap 2.34M

Industry Biotechnology

1.6000

-3.03%

Mkt Cap 44.757M

Industry Biotechnology

Valuation Measures

As of 5/10/2024

Market Cap

24.51M
Enterprise Value

-25.86M
Trailing P/E

--
Forward P/E

--
PEG Ratio (5yr expected)

--
Price/Sales (ttm)

--
Price/Book (mrq)

0.51
Enterprise Value/Revenue

--
Enterprise Value/EBITDA

--

Financial Highlights

Profitability and Income Statement

Profit Margin

0.00%
Return on Assets (ttm)

-25.16%
Return on Equity (ttm)

-36.49%
Revenue (ttm)

--
Net Income Avi to Common (ttm)

-20.84M
Diluted EPS (ttm)

-2.5800

Balance Sheet and Cash Flow

Total Cash (mrq)

50.53M
Total Debt/Equity (mrq)

0.64%
Levered Free Cash Flow (ttm)

-14.36M

LSTA does not have Company Insights

IMNN Imunon, Inc.

1.4800

+7.25%

KA Kineta, Inc.

0.5199

-9.27%

CGTX Cognition Therapeutics, Inc.

1.9500

+0.52%

IKNA Ikena Oncology, Inc.

1.3200

+2.33%

DOMH Dominari Holdings Inc.

2.0500

-2.84%

ERNA Eterna Therapeutics Inc.

2.1400

+2.39%

CMRA Comera Life Sciences Holdings, Inc.

0.0212

0.00%

AIMD Ainos, Inc.

1.0600

-0.93%

IVVD Invivyd, Inc.

2.3700

+4.87%

LABP Landos Biopharma, Inc.

22.21

-0.25%

CING Cingulate Inc.

0.7909

+3.24%

INAB IN8bio, Inc.

1.0200

+0.99%

SABS SAB Biotherapeutics, Inc.

4.0900

+1.87%

LUMO Lumos Pharma, Inc.

2.8750

-1.54%

ELEV Elevation Oncology, Inc.

3.5400

+7.93%

FRTX Fresh Tracks Therapeutics, Inc.

0.9001

-1.23%